Author

Eleni Markoutsa

University of South Florida

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 2 Cancer Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:mouse· 4 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Shyam S. MohapatraiD· 4 shared Subhra MohapatraiD· 4 shared Karthick MayilsamyiD· 3 shared Akshata Patne· 2 shared Jennifer GuerguesiD· 2 shared Kristina Tosi· 2 shared Kristof WilliamsiD· 2 shared Lei WangiD· 2 shared

Activity by Year

2026-2026 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersPhysiology

Shyam S. MohapatraORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Dendrimer Delivered shRNA Targeting the CCL20-CCR6 Axis Suppresses Complement-Mediated Microglial Synaptic Pruning and Ameliorates Chronic Neuroinflammation After Repetitive Traumatic Brain Injury

Karthick Mayilsamy, Parthvi Bharatkumar Patel, Ryan J. Green, Sashank Bikkasani, Kristina Tosi, Shreyasi Majumdar, Santosh Kumar Prajapati, Eleni Markoutsa, Tiara Wolf, Jennifer Guergues, Stanley M. Stevens, Allison Willing, Shyam Mohapatra, Subhra Mohapatra

This study identifies the CCL20-CCR6 axis as a driver of chronic neuroinflammation after rTBI and shows that shRNA targeting this axis reduces synaptic loss and improves behavioral outcomes.

Molecular Therapy · Oct 1, 2026Peer-reviewedNeuroscience

CCL20-CCR6 Signaling as a Prognostic Biomarker and Therapeutic Target in Temozolomide-Resistant Glioblastoma

Ryan J. Green, Karthick Mayilsamy, Erin Anglin, Kristina Tosi, Sashank Bikkasani, Eleni Markoutsa, Parthvi Bharatkumar Patel, Tiara Wolf, Jennifer Guergues, Stanley M. Stevens, Ganesh V. Halade, Shyam Mohapatra, Subhra Mohapatra

This study identifies CCL20-CCR6 signaling as a prognostic biomarker and therapeutic target in temozolomide-resistant glioblastoma, showing that its inhibition enhances treatment response and induces tumor cell death.

bioRxiv · Aug 27, 2026 · PreprintCancer Biology

Glomerular-Targeted Delivery of Low-Dose Prednisolone Attenuates Established Lupus Nephritis in MRL/lpr Mice.

Kristof Williams, Georgina Agyekum, Akshata Patne, Eleni Markoutsa, David Raj Chellappan, Nathan Hall, Zhi Tian, Nohely Hernandez Soto, Sebastian Cuadrao, Isabella Lozonschi, Liying Fu, Lilliana Haight, Rahul Sharma, Subhra Mohapatra, Lei Wang, , Ruisheng Liu

This study shows that targeted delivery of low-dose prednisolone via collagen IV 3-targeted nanoparticles reduces lupus nephritis in MRL/lpr mice.

bioRxiv · Aug 6, 2026 · PreprintPhysiology

Glomerulus-Targeted Nanotherapy via Collagen IV-α3 Binding Enhances Renal Immunoregulation in Lupus Nephritis

Lei Wang, Eleni Markoutsa, Rajkumar Venkatadri, Rahul Sharma, Carlos Esquivel, Akshata Patne, Jin Wei, Jie Zhang, Kristof Williams, William Lawless, Amtul Muskan, Liying Fu, Karthick Mayilsamy, Subhra Mohapatra, Shyam Mohapatra, Ruisheng Liu

This study develops glomerulus-targeted nanotherapy using collagen IV-α3 binding peptides to improve renal function and reduce inflammation in lupus nephritis.

Clinical Science · Aug 5, 2026Peer-reviewedPhysiology